A Novel Whole-genome Amplification (WGA) Method
for the Detection of Chromosomal Abnormalities 

Improving the outcomes of in vitro fertilization (IVF) treatment means being able to better predict the risk of miscarriage. One of the factors affecting the success of pregnancy is embryonic aneuploidy.

A Novel Whole-genome Amplification (WGA) Method for the Detection of Chromosomal Abnormalities Preimplantation genetic testing (PGT) is a way to screen or test embryos generated in the lab for a presence or absence of genetic alterations that can reduce the embryo’s viability or affect the health of the fetus.

Download this poster to learn more about the newly developed dedicated PGT-A reference materials and their performance.

 

Complete this form for your free download:

We’re committed to your privacy. SeraCare will not share or sell your data. View our privacy policy below for details.